scispace - formally typeset
A

Alexandra Giatromanolaki

Researcher at Democritus University of Thrace

Publications -  360
Citations -  26647

Alexandra Giatromanolaki is an academic researcher from Democritus University of Thrace. The author has contributed to research in topics: Angiogenesis & Cancer. The author has an hindex of 66, co-authored 340 publications receiving 22956 citations. Previous affiliations of Alexandra Giatromanolaki include John Radcliffe Hospital.

Papers
More filters
Journal ArticleDOI

The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer

TL;DR: In this paper, the expression of two major enzymes involved in arginine depletion and replenishment, namely arginase ARG2 and argininosuccinate synthase ASS1, were examined in a series of 98 NSCLCs.
Journal Article

Abdominal wall endometriosis--ultrasound research: a diagnostic problem.

TL;DR: A case of a young woman with subcutaneous endometriosis under the surgical scar of a previous cesarean section is described and physical examination, ultrasound findings, histopathological features and differential diagnostic problems are discussed.
Journal ArticleDOI

Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy

TL;DR: It is suggested that although apoptosis‐related proteins may have a role in defining response to taxanes, parameters related to tumors' vasculature, such as drug availability or angiogenic tissue regeneration, may be equally important.
Journal ArticleDOI

Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer

TL;DR: The expression of CD47/SIRPα molecules in a series of 98 NSCLCs, in parallel with the infiltration of tumor stroma by CD68+ macrophages, tumor-infiltrating lymphocytes (TILs), and PD-L1/PD-1 molecules found that extensive membranous CD47 expression by cancer cells characterized 29/98 cases.